Evidence map›Paper›PMID 40845009›Full record

ArticlePloS one2025

Downhill running regulates cardiac immune response through GCN2.

Xinyue Bai, Wanting Zhang, Yingyue Zhang, Xin Xu

Abstract read
In one paragraph

Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Xinyue BaiSchool of Exercise and Health, Shanghai University of Sport, Shanghai, China.ORCID https://orcid.org/0000-0003-1110-609X
Wanting ZhangSchool of Exercise and Health, Shanghai University of Sport, Shanghai, China.ORCID https://orcid.org/0009-0004-0412-6126
Yingyue ZhangSchool of Exercise and Health, Shanghai University of Sport, Shanghai, China.
Xin XuResearch Institute for Doping Control, Shanghai University of Sport, Shanghai, China.ORCID https://orcid.org/0000-0003-1919-7563

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Downhill running (DR) has recently emerged as a promising exercise modality for cardiac rehabilitation, but the effect and mechanism of DR on myocardium remains unclear. General control nonderepressible 2 (GCN2), an eukaryotic initiation factor 2α (eIF2α) kinase, is beneficial to the heart when it is deficiency. The current study aimed to explore whether the GCN2 is associated with cardioprotective effects in downhill running. Eight-week-old male wild type (WT) mice and GCN2 knock out (KO) mice were randomly divided into WT control (n = 6), WT exercise(n = 5), GCN2 KO control(n = 5), and GCN2 KO exercise(n = 5) groups. Mice in the exercise groups were subjected to a single session of downhill running treadmill exercise training. In WT mice, DR increased the proportion of basophils, decreased the percentage of lymphocytes in the blood, and decreased the expression of GCN2, Ifn-γ, Tgf-βr1 and immune cell markers in the myocardium. Compared with WT mice, GCN2 KO mice decreased the proportion of monocytes and neutrophils in the blood, decreased expression of Ifn-γ, Tgf-βr1 and immune cell markers, and increased expression of Il-12α in the myocardium. In GCN2 KO mice, DR increased the expression of immune cell markers in the myocardium. DR and GCN2 KO both reduced TGF-β1 expression, and elevated p-eif2a expression in the myocardium. This finding demonstrated that downhill running alters inflammation and immune response in the myocardium, which is associated with GCN2.

Indexed as

MyocardiumPhysical Conditioning, AnimalProtein Serine-Threonine KinasesRunningAnimalsMaleMiceMice, Inbred C57BLMice, KnockoutEif2ak4 protein, mouseProtein Serine-Threonine Kinases

Identifiers

PMID40845009
PMCPMC12373192

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.